News | October 21, 2009

SenoRx Ranked Among the Fastest Growing Companies in North America

October 21, 2009 - SenoRx today announced that it ranked among the fastest growing companies in Deloitte's 2009 Technology Fast 500, a ranking of the 500 fastest growing technology, media, telecommunications and life sciences and clean technology companies in North America.

Rankings are based on percentage revenue growth during the five year period from 2004 to 2008. SenoRx grew 240 percent during this period, ranking it number 460 of the list.

Lloyd Malchow, SenoRx chairman and CEO, credits the significant progress that the company has made in creating a strong presence in the growing global market for interventional diagnostic and therapeutic products for breast care.

Technology Fast 500 provides a ranking of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. This ranking is compiled from nominations submitted directly to the Technology Fast 500(TM) website, and public company database research conducted by Deloitte LLP. Technology Fast 500 award winners for 2009 are selected based on percentage fiscal year revenue growth during the five year period from 2004 to 2008.

In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or proprietary technology that contributes to a significant portion of the company's operating revenues. Using other companies' technology or intellectual property in a unique way does not satisfy this requirement. Consulting companies, professional service firms, etc. are not eligible unless they have proprietary technology that contributes to a significant portion of their operating revenues.

Technology Fast 500 award eligibility requirements include a base-year operating revenues of at least $50,000 USD or CD, and current-year operating revenues of at least $5 million USD or CD. Additionally, these revenues must have more than doubled between 2004 and 2008. Also companies must be in business for a minimum of five years, and be headquartered within North America.

For more information: www.senorx.com

Related Content

Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Australia's Monash Cancer Centre Treats First Early-Stage Breast Cancer Patient With Xoft System
News | Brachytherapy Systems, Women's Healthcare | May 01, 2017
iCAD Inc. announced the first early-stage breast cancer patient was treated in Australia with intraoperative radiation...
New Clinical Data on Xoft System Presented at American Brachytherapy Society Annual Meeting
News | Brachytherapy Systems, Women's Healthcare | April 20, 2017
iCAD Inc. announced that updated clinical data on the use of intraoperative radiation therapy (IORT) using the Xoft...
Concure Oncology, Breast Microseed Treatment, one day, low-dose rate brachytherapy, LDR
Technology | Brachytherapy Systems, Women's Healthcare | May 12, 2016
Concure Oncology/Breast Microseed Inc. announced the launch of its one-time, one-hour radiation treatment option for...
News | Brachytherapy Systems, Women's Healthcare | April 20, 2016
Cianna Medical Inc. announced new clinical data evaluating the Savi Scout breast localization and surgical guidance...
Gamma pro, kubtec
News | Breast Imaging | November 04, 2015
Kubtec announced the launch of the Gamma-Pro Node and Seed Location System for use in breast seed location and sentin
iCAD, Xoft Axxent, electronic brachytherapy, eBx, clinical studies, ASTRO 2015, radiation therapy

Xoft Axxent image courtesy of iCAD Inc.

News | Brachytherapy Systems | October 21, 2015
iCAD Inc. presented updated clinical data, hosted in-booth clinician presentations and showcased the latest in...
APBI, accelerated partial breast irradiation, multicatheter brachytherapy, breast conserving surgery, whole breast irradiation, WBI, ASTRO 2015
News | Brachytherapy Systems, Women's Healthcare | October 19, 2015
For some early-stage breast cancer patients, accelerated partial breast irradiation (APBI) using multicatheter...
Theragenics, Advanced Radiation Therapy LLC, AccuBoost, early stage breast cancer, brachytherapy
News | Brachytherapy Systems, Women's Healthcare | August 07, 2015
Theragenics Corp. has reached an agreement with Advanced Radiation Therapy LLC to distribute the AccuBoost technology...
Cianna Medical, SAVI Scout, breast surgical guidance system

Photo courtesy of Cianna Medical

Technology | December 16, 2014
Cianna Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for the SAVI Scout surgical guidance...
Overlay Init